Association of Menopause and Hormone Replacement Therapy with Hearing Loss
Annals of Otology, Rhinology & Laryngology · 2026-08 · 135 (8) · 607-615
DOI: 10.1177/00034894261435259 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Otology, Rhinology & Laryngology, online erschienen am 06.04.2026. Verfasst von Jonathan Z Hsu und 3 weiteren Autor:innen. Beteiligte Einrichtung: California University of Science and Medicine, Colton, CA, USA. Hauptthemen laut MEDLINE: Menopause, Hearing Loss, Estrogen Replacement Therapy, Hormone Replacement Therapy. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Objective
Estrogen has been found to impact cochlear blood flow and auditory function, but epidemiological studies on menopause and hearing are inconsistent. This study investigates the associations of menopause, its age at onset, reproductive lifespan, and hormone replacement therapy (HRT) with hearing loss in adult women in the US.
Methods
Study cohort includes 1778 adult women (40-69 years), from the National Health and Nutrition Examination Survey 2011 to 2012 and 2015 to 2016 who had complete data on audiometry and reproductive health. Hearing loss was defined based on speech-frequency pure-tone average (0.5, 1, 2, and 4 kHz) in better hearing ear. Menopause status was self-reported. Multivariable regression analyses were performed to explore the associations of menopause, age at onset, reproductive lifespan, and HRT with hearing loss.
Results
After adjusting for age, demographics, medical comorbidities, and noise exposure, there was no significant association between binary postmenopausal status and hearing loss (β: 0.92 dB, [95% CI: −1.02 to 2.86]). When further considering age of menopause onset and reproductive lifespan, we found that late onset of menopause (vs early onset) was significantly associated with the better hearing (β: −4.60 dB, [95% CI: −8.42 to −0.79]) and longer reproductive lifespan was significantly associated with better hearing (β: −0.16 dB per year, [95% CI: −0.32 to −0.002]). Comparing reproductive lifespan quartiles, the fourth quartile was significantly associated with better hearing relative to the first quartile (β: −4.86 dB, [95% CI: −8.28 to −1.44]). Among post-menopausal women, there was no significant association between hearing loss and HRT (β: 0.45 dB, [95% CI: −1.69 to 2.58]).
Conclusion
While menopausal status was not significantly associated with hearing loss, later onset of menopause and longer reproductive lifespan were associated with better hearing. Future studies should evaluate the clinical significance of the associations between hearing and reproductive health and potential causal relationships. Level of evidence: 2b
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- California University of Science and Medicine, Colton, CA, USA.
- Georgia Institute of Technology, Atlanta, GA, USA.
- Caruso Department of Otolaryngology-Head & Neck Surgery, Keck School of Medicine of the University of Southern California, Los Angeles, CA, USA.
ORCID-Profile: Jonathan Z Hsu, Breana Nguyen, Janet S Choi
Zitieren
APA
Hsu, J. Z., Gu, K., Nguyen, B., & Choi, J. S. (2026). Association of Menopause and Hormone Replacement Therapy with Hearing Loss. Annals of Otology, Rhinology & Laryngology, 135(8), 607-615. https://doi.org/10.1177/00034894261435259
Vancouver
Hsu JZ, Gu K, Nguyen B, Choi JS. Association of Menopause and Hormone Replacement Therapy with Hearing Loss. Annals of Otology, Rhinology & Laryngology. 2026;135(8):607-615. doi:10.1177/00034894261435259
BibTeX
@article{Hsu2026,
author = {Hsu, Jonathan Z and Gu, Kaiqi and Nguyen, Breana and Choi, Janet S},
title = {Association of Menopause and Hormone Replacement Therapy with Hearing Loss},
journal = {Annals of Otology, Rhinology & Laryngology},
year = {2026},
volume = {135},
number = {8},
pages = {607--615},
doi = {10.1177/00034894261435259}
}
EUVIMED